Care from independent, U.S.-licensed providers · Free, discreet shipping
Get startedYou're on the list
We'll email you as soon as it's available.
A composite score across four everyday signals linked to GH output: sleep depth, recovery, daytime energy, and (optionally) IGF-1. It’s an educational way to think about your habits. It can’t measure your hormones or diagnose anything.
Fill in your profile to see a GH-axis score across sleep, recovery, energy, and (optionally) IGF-1.
Your score is educational only. If you have concerns, talk to a licensed provider.
Score range is 0-30. The bands aren’t diagnostic. They’re a structured way to think about your sleep, recovery, and energy habits.
Sleep, recovery, and energy look solid. Keep doing what you’re doing and focus on consistent habits.
Some pillars are slipping. Start with sleep, training, and recovery. Consider talking to a licensed provider if concerns persist.
Several pillars are low. Worth discussing with a licensed provider alongside sleep and lifestyle work.
Sleep, recovery, and energy all scored low. Consider talking to a licensed provider about your symptoms and health history. This score is not a diagnosis.
Growth-hormone output peaks in your late teens and declines steadily, roughly 1-2% a year after 30. Drag the slider to see how much the axis shifts with age, then calculate your score above to plot where your own pillars land.
Growth hormone is hard to measure directly, serum GH is pulsatile and unreliable. The downstream tissue-level effects are the practical signal.
Much of daily GH release happens during deep, slow-wave sleep, so sleep depth, wake-ups, and how rested you feel are practical everyday signals to track. Many things besides GH affect sleep.
Growth hormone plays a role in tendon, ligament, and connective-tissue repair. Slow recovery from normal daily activity and recurring soft-tissue issues can be signs of age-related GH-axis decline in adults over 40. Many other factors affect recovery too.
The GH axis supports daytime energy, recovery, and sleep-driven restoration. Lower energy has many possible causes, so this pillar is a rough signal only.
IGF-1 is the longer-acting messenger that mediates most of GH’s peripheral effects. Reference ranges vary by age, sex, and lab, and only a clinician can interpret your result. Add a recent value if you have one; the tool uses it as a rough input only.
Growth hormone is released in pulses, mostly during deep, slow-wave sleep. Your pituitary sends the signal, your liver responds by producing IGF-1, and that downstream marker is what a blood test actually measures. It’s the system behind overnight tissue repair, recovery, and how rested you feel the next day.
Output peaks in your late teens and then declines steadily, roughly 1-2% per year after age 30. By your 40s and 50s, total daily GH can be a fraction of what it once was, which is part of why sleep feels lighter and recovery takes longer even when nothing else has changed.
There are also provider-guided options that work upstream, such as sermorelin, a GHRH peptide that signals your own pituitary to release GH rather than replacing the hormone directly. Whether anything like that is appropriate for you is a decision a U.S.-licensed provider makes after reviewing your health history. Compounded medications are not FDA-approved.
Your score is educational, not a diagnosis. If you’re curious about sermorelin, a U.S.-licensed provider can review your health history and decide whether it’s appropriate for you.
Learn about sermorelin →This is a structured, educational way to think about the growth-hormone axis using downstream signals like sleep and recovery. The bands are not diagnostic; GH status is assessed by a clinician. It is not medical advice.
How this tool calculates
Your answers are scored across four pillars: sleep (0-9), recovery (0-9), daytime energy (0-6), and IGF-1 (0-6, or a neutral 3 if you skip it), for a total of 0-30. The bands and the lifetime chart are a simple educational model, not a validated clinical scale.
Peer-reviewed sources
Important. This tool is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The tool does not prescribe medication, recommend specific dosing, or substitute for clinical evaluation. Compounded medications referenced anywhere on this site are not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Treatment decisions are made only by a licensed U.S. provider after an individual evaluation.
ShyftMD offers compounded sermorelin and compounded semaglutide, prescribed by independent, U.S.-licensed providers through Wasef Health, PC when they decide it is appropriate. Compounded drug products are not approved or evaluated for safety, effectiveness, or quality by the FDA. ShyftMD is not associated with, endorsed by, or affiliated with the manufacturers of FDA-approved branded weight-loss medications, and does not sell or supply those branded products. Anyone interested in an FDA-approved branded medication should consult a licensed healthcare provider or pharmacist. Individual results vary; no specific result is promised, and weight management requires ongoing medical guidance.
